Fano MY

Language: Spanish
References: 21
Page: 82-89
PDF size: 101.78 Kb.

ABSTRACT

Introduction: the Blepharitis is defined like a chronic inflammation of the eyelids borders. It produces alterations of eyelids borders, Meibomio glands, and cornea, conjunctive and lachrymal film, giving place to complications. It has special importance due to their high incidence.
Objective: evidencing clinical manifestations and ophthalmologic complications in patient with mixed Blepharitis.
Case Presentation: a male patient of 82 years, black race with antecedents of health consults because an increase of volume of the lower left lid of eye for 2 years accompanied by secretion and shed tears, without previously treatment. The ophthalmologic exam evidences reversed lower lid, lashes that contact with the conjunctive. We observed a palpable border with a blush eyelid and scabs, telangiectasias, dilation of the holes of Meibomio glands, tumor injuries in number of 3 with a size between 2 and 4 mm, hard and painless lower plate, moderate conjunctival injection, and scarce foamy secretion. The Schirmer’s test I 9 mm and plate break down up to 5 seconds. It was diagnosed complicated mixed Blepharitis with multiple chalazion, entropion and dry keratoconjunctivitis. Previous informed consent treatment was indicated withtetracycline, prednisolone, artificial tears and surgical treatment of multiple chalazion, being achieved the disappearance of the entropion. It was carried out the differential diagnosis with carcinoma of sebaceous glands, cicatricial pemphigus and Stevens-Johnson´s syndrome.
Conclusions: the Blepharitis is an important cause of ocular morbidity due to the changes produced on the anatomy of the lids and lachrymal film with the consequent damage to the ocular surface.

REFERENCES

1. Kanski JJ. Oftalmología Clínica. 5 ed. Madrid: Elsevier; 2004.

2. Perdomo Delgado J, Acosta Quintana K, Palacios Fernández S, Carrero Figueroa MV, González Pla EA. Homeopatía y Oftalmología: las Blefaritis. Rev Cub Med Mil revista en la Internet. 2007 Sep; 36(3): Citado 2015 Ene 12. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 65572007000300007&lng=es

3. Perdomo Delgado J, Palacios Fernández S, Acosta Quintana K, Carrero Figueroa MV, González Pla Evelyn A, Soler Cárdenas S. Evaluación de la efectividad del tratamiento homeopático en pacientes con diagnóstico clínico de Blefaritis anterior. Rev Cub Med Mil revista en la Internet. 2007 Sep; 36(3): Citado 2015 Ene 12. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 65572007000300003&lng=es

4. Blackie CA, Korb DR, Knop E, Bedi R, Knop N, Holland EJ. Nonobvious obstructive meibomian gland dysfunction. Cornea. 2010;29(12):1333-45.

5. Knop E, Knop N, Millar T. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011;52(4):1938-78.

6. Green-Church KB. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland. IOVS. March. 2011;52(4):1938-7.

7. Merayo Lloves J. Conceptos Actuales en Ojo Seco. Del Síndrome a la Enfermedad.Internet Grupo Español de Superficie Ocular y Cornea (GESOC); España.2012. Citado 13 Dic 2013. Disponible en: http://www.oculab.com/ficheros/ojoseco.pdf

8. Pult H, Riede-Pult BH. Non-contact meibography in diagnosis and treatment of nonobvious meibomian gland dysfunction. J Optom. 2012;5(1):2-5.

9. Korb DR, Blackie CA. Restoration of Meibomian gland functionality with novel thermodynamic treatment device-a case report. Cornea. 2010;29(28):930-3.

10. Arita R. Proposed diagnostic criteria for seborrheic meibomian gland dysfunction. Cornea. 2010;29(28):980-4.

11. Nelson JD, Shimazaki J, Benitez-del-Castillo JM. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930-7.

12. Schaumberg DA, Nichols JJ, Papas EB. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994-2005.

13. Qazi Y, Cavalcanti B, Cruzat A. Immune response in meibomian gland dysfunction (MGD) and the effect of anti-inflammatory therapy: an in vivo confocal microscopy (IVCM) study. ARVO Meeting Abstracts. 2012;53(6):593.

14. Hamrah P, Qazi Y, Blackie CA, Korb DR. Subclinical inflammation may explain the persistence of refractory dry eye symptoms after apparently successful treatment for meibomian gland dysfunction. ARVO Meeting Abstracts.2012;53(6):594.

15. Geerling G, Tauber J, Baudouin C. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52(4):2050-64.

16. Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. Cornea. 2010;29(10):1145-52.

17. Maskin SL, Kantor K. Intraductal meibomian gland probing with adjunctive intraductal microtube steroid injection (MGPs) for meibomian gland dysfunction (MGD). Invest Ophthalmol Vis Sci. 2011;52(6):381-7.

18. Maskin L. Dry Eye Relief. Peeling back layers to reveal root causes, select the right tools and improve tear quality. Ophthalmol Maneg. 2011 citado 5 dic 2013. Disponible en: http://www.ophthalmologymanagement.com/articleviewer.aspx?articleId=105865

19. Fadlallah A, Rami HE, Fahd D, Dunia I, Bejjani R, Chlela E, et al. .Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis. Arq. Bras. Oftalmol. revista en la Internet. 2012 Jun; 75(3): 178-182. Citado 2015 Ene 12 Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004- 27492012000300006&lng=es

20. Ramírez García LK, Díaz AM, Gómez Cabrera CG, Vigoa Aranguren L, Rojas Rondón I, Carrazana Pérez YM. Carcinoma de glándulas sebáceas palpebrales. Rev Cubana Oftalmol revista en la Internet. 2014 Mar; 27(1): 139-147. Citado 2015 Ene 12. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21762014000100014&lng=es

21. Arronte Alarcón MT. Carcinoma de glándulas sebáceas. Un estudio clínico patológico de 10 años. Rev Méx Oftalmol. 2013;87(1):19-24